referring to dallasnews
Dallas-based renal cancer therapy developer raises $52.4 million
Dallas-based renal cancer therapy developer raises $52.4 million
Peloton Therapeutics, Inc. has raised $52.4 million in venture capital, which it plans to use to support clinical trials on a novel kidney cancer treatment it has developed.The Dallas-based biotechnology company completed a Series D financing round, and added new investor Foresite Capital Management, a private equity and venture capital firm from San Francisco that focus on emerging healthcare drug and device opportunities.The announcement about the latest financing round was posted on Thursday.
additionally wtkr
Fighting cancer with proton therapy and hope in Hampton
Fighting cancer with proton therapy and hope in Hampton
Please enable Javascript to watch this videoCancer has surpassed heart disease as the number one killer in Virginia but today there are more ways than ever to fight the disease and you can do it with fewer side affects.Joining us on Coast Live are Dr. Allan Thornton of the Hampton University Proton Therapy Institute and cancer survivor, Larry Davis.The 6th Annual Gala of Hope is Saturday, October 29 at 6pm at the Hampton Roads Convention Center.
in the same way mit
Gene therapy technique may help prevent cancer metastasis
Gene therapy technique may help prevent cancer metastasis
The spread of malignant cells around the body, known as metastasis, is the leading cause of mortality in women with breast cancer.Now, a new gene therapy technique being developed by researchers at MIT is showing promise as a way to prevent breast cancer tumors from metastasizing.The treatment, described in a paper published today in the journal Nature Communications, uses microRNAs — small noncoding RNA molecules that regulate gene expression — to control metastasis.
No comments:
Post a Comment